Global Shift in R&D

As US industry's share of global biomedical R&D has fallen, China and Japan raise their stake in the game.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

I hope the new leaders will

I hope the new leaders will be able not just to spend more but also to generate substantial innovations

I hope the new leaders will

I hope the new leaders will be able not just to spend more but also to generate substantial innovations